ORAI1 and central nervous system cancer: This finding is consistent with the results of a previous study reporting that knockdown of ORAI1 in glioma can significantly reduce receptor-dependent Ca2+ influx and inhibit Pyke activity, thereby inhibiting glioma cell invasion and metastasis (49).